Cocaine-M artifact (benzoylecgonine-HO-ring) 2 ME isomer-1
Compound with spectra: 1 MS (LC)
| SpectraBase Compound ID | 8SWqMlhNYjX |
|---|---|
| Mol Weight | 0.0 g/mol |
| Molecular Formula | C18H21NO4 |
| Exact Mass | 0.0 g/mol |
| Copyright | Copyright © 2018-2025 Wiley-VCH GmbH. All Rights Reserved. |
|---|---|
| Source of Spectrum | Maurer/Meyer/Helfer/Weber c/o Saarland University Homburg/Saar |
| Technique | HCD |
Cocaine-M artifact (benzoylecgonine-HO-ring) 2 ME isomer-2
(1a.alpha.,3a.alpha.,4.beta.,5a.alpha.6.alpha.,8.beta.,8a.alpha.,8b.beta.,10.alpha.,10a.beta.,10b.beta.,10c.alpha.)-4-[(1,1-Dimethylethyl)dimethylsiloxy]tetradecahydro-10-[(2-methoxyethoxy)methoxy]-8-(methoxymethoxy)-6,8b-dimethyl-1H-naphth[2',1',8':3,4,5]azuleno[1.8-bc]furan-3(1aH)-one
6H,16H,31H-5,9:15,19-Dimethano-10,14-metheno-26,30-nitrilo-5H,25H-dibenzo[b,s][1,21,4,8,14,18]dioxatetraazacyclooctacosine-34,36-dione, 7,8,17,18-tetrahydro-35-methoxy-1,3,21,23-tetramethyl-
2-Propenoic acid, 3-phenyl-, 1,1a,1b,1c,2a,3,3a,4,6a,6b,7,8-dodecahydro-3a,6b-dihydroxy-1,1,5,7-tetramethyl-4-oxo-2a-[[(1-oxo-3-phenyl-2-propenyl)oxy]methyl]-8aH-cyclopropa[5',6']benz[1',2':7,8]az uleno[5,6-b]oxirene-8,8a-diyl ester, [1aR-(1a.alpha.,1b.beta.,1c.beta.,2a.beta.,3a.beta.,6a.alpha.,6b.alpha.,7.alpha.,8.beta.,8a.alpha.)]-
13',16':18',21'-dietheno-1,1''-diethyl-3',14',20',31'-tetramethyldispiro[piperidine-4,17'-[5,12,22,29]tetraoxa[37,40,41]triazatetracyclo[31.13.1.0.(4,45).0(30,35)]heptatetraconta-1',3',13',15',18',20',30',34',35',45'-decaene-47',4''-piperidine]-38',42'-dione
4H-9,12:15,18-Dietheno-28,31-imino-26,23-methenopyrrolo[2,3-n][1,19,6]dioxaazacyclohentriacontine-6,21,24(5H,22H,25H)-trione, 30-ethyl-2-[(3-ethyl-1,5-dihydro-4-methyl-5-oxo-2H-pyrrol-2-ylidene)methyl]-8,13,14,19-tetrahydro-3,29,34-trimethyl-, (Z,Z,Z)-
Nickel, (4,4,5,5,9,9,10,10,14,14,15,15,19,19,20,20-hexadecamethyl-21,27-dioxa -2,12,28,29,30,31-hexaazahexacyclo[9.9.7.1(1,18).1(3,6).1(8,11).1(13,16)]hentriaconta-2,6(31),7,12,16(29),17-hexaenato(2-)-N28,N29,N30,N31)-, (SP-4-1)-
1-(4-amino-1,2,5-oxadiazol-3-yl)-N'-[(E)-(2-chloro-5-nitrophenyl)methylidene]-5-isopropyl-1H-1,2,3-triazole-4-carbohydrazide
Acetic-D3 acid, 2-[10,14-diacetyl-5-[3-(benzoylamino)propyl]-3,3a,4,5,6,7,8,9,10,11,12,13,14,15-tetradecahydro-3-(4-methoxyphenyl)-4-oxo-1,16-ethenofuro[3,4-l][1,5,10]triazacyclohexadecin-15-yl]ester
21H,23H-Porphine-2,18-dipropanoic acid, 7,12-bis[1-[1-[ethenyl-2,18-bis(3-methoxy-3-oxopropyl)-3,17,?,?-tetramethyl-21H,23H-porphinyl]ethoxy]ethyl]-3,8,13,17-tetramethyl-, dimethyl ester
This compound is available in the following databases:
Maurer, Meyer, Helfer, Weber: LC-HR-MS & MS Library of Drugs, Poisons, and Their Metabolites
Author: Hans H. Maurer, Markus Meyer, Andreas G. Helfer, Armin A. Weber
Developed by toxicologist Hans H. Maurer and his team, the Maurer/Meyer/Helfer/Weber LC-HR-MS/MS Library of Drugs, Poisons, and Their Metabolites consists of spectra for parent drugs or poisons, and their metabolites or artifacts, in various compound classification groups. This metabolite-based library helps minimize the risk of false negative LC-MS results. Learn more.